Filing Flows › Manhattan Associates (MANH) › R&D spending
Manhattan Associates (MANH) R&D spending by quarter
Manhattan Associates' R&D spending was $35.5M in Q3 2026 (third quarter 2026), +2% from Q2 2026. Over the last 7 quarters it ranged from $34.8M (Q2 2026) to $38.5M (Q4 2025).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $35.5M | +2% | -2% |
| Q2 2026 | $34.8M | -7% | -0.3% |
| Q1 2026 | $37.3M | -3% | +6% |
| Q4 2025 | $38.5M | +6% | — |
| Q3 2025 | $36.4M | +4% | — |
| Q2 2025 | $34.9M | -1% | — |
| Q1 2025 | $35.3M | — | — |
Q3 2026 at a glance
Manhattan Associates, Q3 2026: revenue $306M (+11% year over year), operating margin 26.5%, net earnings $61.3M, operating cash flow $68.6M. The chart follows the revenue to costs, profit and cash.
Questions
What is Manhattan Associates' R&D spending?
Manhattan Associates' R&D spending was $35.5M in Q3 2026 (third quarter 2026), +2% from Q2 2026.
How has Manhattan Associates' R&D spending changed?
Over the last 7 quarters it ranged from $34.8M (Q2 2026) to $38.5M (Q4 2025).